CCL5 and hepatocellular carcinoma: It is noteworthy that Tregs recruited by circulating tumor cells (CTCs)-derived CCL5 in HCC can promote CTC metastatic seeding, which may contribute to the development of novel anti-metastasis treatment for HCC [162].